Research Article

The Antileukemia Activity of Natural Product HQ17(3) Is Possibly Associated with Downregulation of miR-17-92 Cluster

Figure 5

Effect of HQ17(3) in combination with anticancer drugs. Leukemia cell Molt (a) and Ramos (b) were treated with different doses of anticancer drug with/without 3 μM of HQ17(3) for 24 h. Cell viability was measured. Viability of untreated group is designated to be 100%. The experiments were conducted in triplicate. Means ± SD are shown.